Original Text: |
    Has had disease progression on more than two cyclin-dependent kinase (CDK)4/6 inhibitors. Adjuvant abemaciclib is allowed but must have progressed on palbociclib or ribociclib.
Disease/Condition: CDK4/6 Inhibitor, Abemaciclib, Palbociclib, Ribociclib
Procedure: none
Drug: none
Biomarker: none
Computable Rule: |
    LK MTS == False, MTS == False, MTS == False, MTS == False
